Genome-wide DNA methylation and RNA expression profiles identified RIPK3 as a differentially methylated gene in Chlamydia pneumoniae infection lung carcinoma patients in China

References

• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. doi:10.3322/caac.2126225651787
   PubMed Web of Science ®Google Scholar
• Broaddus VC, Mason RC, Ernst JD, et al. Murray & Nadel’s Textbook of Respiratory Medicine E-Book. Philadelphia: Elsevier Health Sciences; 2015:6.
   Google Scholar
• Pallis AG, Syrigos KN. Lung cancer in never smokers: disease characteristics and risk factors. Crit Rev Oncol Hematol. 2013;88(3):494–503. doi:10.1016/j.critrevonc.2013.06.01123921082
   PubMed Web of Science ®Google Scholar
• Littman AJ, Jackson LA, Vaughan TL. Chlamydia pneumoniae and lung cancer: epidemiologic evidence. Cancer Epidemiol Biomarkers Prev. 2005;14(4):773–778. doi:10.1158/1055-9965.EPI-04-059915824142
   PubMed Web of Science ®Google Scholar
• Hua‑Feng X, Yue‑Ming W, Hong L, et al. A meta‑analysis of the association between Chlamydia pneumoniae infection and lung cancer risk. Indian J Cancer. 2015;52(Suppl 2):e112–e115. doi:10.4103/0019-509X.17250626728667
   PubMedGoogle Scholar
• Rizzo A, Carratelli CR, De Filippis A, et al. Transforming activities of Chlamydia pneumoniae in human mesothelial cells. Int Microbiol. 2014;17:185–193. doi:10.2436/20.1501.01.22126421735
   PubMed Web of Science ®Google Scholar
• Khan S, Imran A, Khan AA, et al. Systems biology approaches for the prediction of possible role of Chlamydia pneumoniae proteins in the etiology of lung cancer. PLoS One. 2016;11(2):e0148530. doi:10.1371/journal.pone.014853026871581
   PubMed Web of Science ®Google Scholar
• Blanco D, Vicent S, Fraga MF, et al. Molecular analysis of a multistep lung cancer model induced by chronic inflammation reveals epigenetic regulation of p16, activation of the DNA damage response pathway. Neoplasia. 2007;9(10):840–852.17971904
   PubMed Web of Science ®Google Scholar
• Portela A, Esteller M. Epigenetic modifications and human disease. Nat Biotechnol. 2010;28(10):1057–1068. doi:10.1038/nbt.168520944598
   PubMed Web of Science ®Google Scholar
• Bibikova M, Barnes B, Tsan C, et al. High density DNA methylation array with single CpG site resolution. Genomics. 2011;98(4):288–295. doi:10.1016/j.ygeno.2011.07.00721839163
   PubMed Web of Science ®Google Scholar
• Ehrich M, Correll D, van Den Boom D. Introduction to EpiTYPER for quantitative DNA methylation analysis using the MassARRAY system. Sequenom Application Note. 2006;1–7.
   Google Scholar
• Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol. 1995;289–300. doi:10.1111/j.2517-6161.1995.tb02031.x
   Web of Science ®Google Scholar
• Haugen A. Molecular biology in the diagnosis of lung cancer. Tidsskrift for Den Norske Laegeforening. 2005;125(23):3283–3285.16327855
   PubMedGoogle Scholar
• Yeung CLA, Tsang TY, Yau PL, et al. Human papillomavirus type 16 E6 suppresses microRNA-23b expression in human cervical cancer cells through DNA methylation of the host gene C9orf3. Oncotarget. 2017;8(7):12158–12173. doi:10.18632/oncotarget.1455528077801
   PubMedGoogle Scholar
• Maeda M, Moro H, Ushijima T. Mechanisms for the induction of gastric cancer by helicobacter pylori infection: aberrant DNA methylation pathway. Gastric Cancer. 2017;20(1):8–15. doi:10.1007/s10120-016-0650-027718135
   PubMedGoogle Scholar
• Chumduri C, Gurumurthy RK, Zadora PK, et al. Chlamydia infection promotes host DNA damage and proliferation but impairs the DNA damage tesponse. Cell Host Microbe. 2013;13(6):746–758. doi:10.1016/j.chom.2013.05.01023768498
   PubMed Web of Science ®Google Scholar
• Schmeck B, Beermann W, N’Guessan PD, et al. Simvastatin reduces Chlamydophila pneumoniae-mediated histone modifications and gene expression in cultured human endothelial cells. Circ Res. 2008;102(8):888–895. doi:10.1161/CIRCRESAHA.107.16130718309103
   PubMed Web of Science ®Google Scholar
• Jovana R, Aleksandra I-K, Elisabeth S, et al. Infection is associated with E-cadherin promoter methylation, downregulation of E-cadherin expression, and increased expression of fibronectin and α-SMA-implications for epithelial-mesenchymal transition. Front Cell Infect Microbiol. 2017;7:253. doi:10.3389/fcimb.2017.0051728660176
   PubMed Web of Science ®Google Scholar
• Schubeler D. Function and information content of DNA methylation. Nature. 2015;517(7534):321–326. doi:10.1038/nature1419225592537
   PubMed Web of Science ®Google Scholar
• Zemach A, McDaniel IE, Silva P, et al. Genome-wide evolutionary analysis of eukaryotic DNA methylation. Science. 2010;328(5980):916–919. doi:10.1126/science.118636620395474
   PubMed Web of Science ®Google Scholar
• Yang C, Li J, Yu L, et al. Regulation of RIP3 by the transcription factor Sp1 and the epigenetic regulator UHRF1 modulates cancer cell necroptosis. Cell Death Dis. 2017;8:e3084. doi:10.1038/cddis.2017.51828981102
   PubMed Web of Science ®Google Scholar
• Koo G-B, Morgan MJ, Lee D-G, et al. Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics. Cell Res. 2015;25:707–725. doi:10.1038/cr.2015.5625952668
   PubMed Web of Science ®Google Scholar
• Cho YS, Challa S, Moquin D, et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell. 2009;137(6):1112–1123. doi:10.1016/j.cell.2009.05.03719524513
   PubMed Web of Science ®Google Scholar
• Silke J, Rickard JA, Gerlic M. The diverse role of RIP kinases in necroptosis and inflammation. Nat Immunol. 2015;16(7):689–697. doi:10.1038/ni.320626086143
   PubMed Web of Science ®Google Scholar
• Sun L, Wang H, Wang Z, et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell. 2012;148(1):213–227. doi:10.1016/j.cell.2011.11.03122265413
   PubMed Web of Science ®Google Scholar
• Li J, McQuade T, Siemer AB, et al. The RIP1/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis. Cell. 2012;150(2):339–350. doi:10.1016/j.cell.2012.06.01922817896
   PubMed Web of Science ®Google Scholar
• Newton K, Dugger DL, Wickliffe KE, et al. Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis. Science. 2014;343(6177):1357–1360. doi:10.1126/science.124936124557836
   PubMed Web of Science ®Google Scholar
• Pasparakis M, Vandenabeele P. Necroptosis and its role in inflammation. Nature. 2015;517(7534):311. doi:10.1038/nature1419125592536
   PubMed Web of Science ®Google Scholar
• Linkermann A, Green DR. Necroptosis. N Engl J Med. 2014;370(5):455–465. doi:10.1056/NEJMra131005024476434
   PubMed Web of Science ®Google Scholar
• Mizumura K, Maruoka S, Gon Y, et al. The role of necroptosis in pulmonary diseases. Respir Investig. 2016;54(6):407–412. doi:10.1016/j.resinv.2016.03.008
   PubMedGoogle Scholar
• Morgan MJ, You-Sun K. The serine threonine kinase RIP3: lost and found. BMB Rep. 2015;48:303–312.25858093
   PubMed Web of Science ®Google Scholar
• Fukasawa M, Kimura M, Morita S, et al. Microarray analysis of promoter methylation in lung cancers. J Hum Genet. 2006;51(4):368–374. doi:10.1007/s10038-005-0355-416435073
   PubMed Web of Science ®Google Scholar
• Tu PH, Elder G, Lazzarini RA, et al. Overexpression of the human NFM subunit in transgenic mice modifies the level of endogenous NFL and the phosphorylation state of NFH subunits. J Cell Biol. 1995;129(6):1629–1640. doi:10.1083/jcb.129.6.16297790359
   PubMed Web of Science ®Google Scholar
• Alberts B. Molecular Biology of the Cell. 4th ed. New York: Garland Science; 2002:652.
   Google Scholar
• Kim MS, Chang X, LeBron C, et al. Neurofilament heavy polypeptide regulates the Akt-β-catenin pathway in human esophageal squamous cell carcinoma. PLoS One. 2010;5(2):e9003. doi:10.1371/journal.pone.000900320140245
   PubMed Web of Science ®Google Scholar
• Jeschke J, Van Neste L, Glöckner SC, et al. Biomarkers for detection and prognosis of breast cancer identified by a functional hypermethylome screen. Epigenetics. 2012;7(7):701–709. doi:10.4161/epi.2044522647880
   PubMed Web of Science ®Google Scholar
• Dubrowinskaja N, Gebauer K, Peters I, et al. Neurofilament heavy polypeptide CpG island methylation associates with prognosis of renal cell carcinoma and prediction of antivascular endothelial growth factor therapy response. Cancer Med. 2014;3(2):300–309. doi:10.1002/cam4.18124464810
   PubMed Web of Science ®Google Scholar
• Revill K, Wang T, Lachenmayer A, et al. Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma. Gastroenterology. 2013;145(6):1424–1435. e1–e25. doi:10.1053/j.gastro.2013.08.055
   PubMed Web of Science ®Google Scholar
• Alholle A, Brini AT, Gharanei S, et al. Functional epigenetic approach identifies frequently methylated genes in Ewing sarcoma. Epigenetics. 2013;8(11):1198–1204. doi:10.4161/epi.2626624005033
   PubMed Web of Science ®Google Scholar
• Shen Z, Chen B, Gan X, et al. Methylation of neurofilament light polypeptide promoter is associated with cell invasion and metastasis in NSCLC. Biochem Biophys Res Commun. 2016;470(3):627–634. doi:10.1016/j.bbrc.2016.01.09426801564
   PubMed Web of Science ®Google Scholar
• Pornour M, Ahangari G, Hejazi S, et al. Dopamine receptor gene (DRD1-DRD5) expression changes as stress factors associated with breast cancer. Asian Pac J Cancer Prev. 2013;15:10339–10343. doi:10.7314/APJCP.2014.15.23.10339
   Google Scholar
• Campa D, Zienolddiny S, Lind H, et al. Polymorphisms of dopamine receptor/transporter genes and risk of non-small cell lung cancer. Lung Cancer. 2007;56(1):17–23. doi:10.1016/j.lungcan.2006.11.00717175058
   PubMed Web of Science ®Google Scholar
• Liao AJ, Su Q, Wang X, et al. Isolation and bioinformatics analysis of differentially methylated genomic fragments in human gastric cancer. World J Gastroenterol. 2008;14(9):1333. doi:10.3748/wjg.14.133318322944
   PubMed Web of Science ®Google Scholar
• Beaulieu JM, Gainetdinov RR. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev. 2011;63(1):182–217. doi:10.1124/pr.110.00264221303898
   PubMed Web of Science ®Google Scholar